Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2026-06-17 16:47:05 ET · period of report 2026-06-16 · accession 0001193125-26-274301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 16:47 | 2026-06-16 | IRWD | Shepard Jay | Dir | A - Grant | $0.00 | +63.5K | 235.0K | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-06-16 | A | A | 63,481 | $0.00 | 235,036 | D | — | — | (F1) The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. |